Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Eur J Cardiothorac Surg. 2021 Apr 13;59(3):577-585. doi: 10.1093/ejcts/ezaa350.
Functional tricuspid regurgitation (fTR) has been amenable to tricuspid valve repair (TVr), with fewer patients needing tricuspid valve replacement (TVR). We sought to review our experience of tricuspid valve surgery for fTR.
A retrospective analysis of adult patients (≥18 years) who underwent primary tricuspid valve surgery for fTR (n = 926; mean age 68.6 ± 12.5 years; 67% females) from January 1993 through June 2018 was conducted. There were 767 (83%) patients who underwent TVr (ring annuloplasty, 67%; purse-string annuloplasty, 33%) and 159 (17%) underwent TVR (bioprosthetic valves, 87%; mechanical valves, 13%). The median follow-up was 8.2 years [95% confidence interval (CI) 7.2-8.9 years].
A greater proportion of patients who underwent TVR had severe right ventricular dysfunction (P < 0.001), severe tricuspid regurgitation (P < 0.001) and congestive heart failure (P = 0.001) while the TVr cohort had a greater proportion with severe mitral valve (MV) regurgitation (P < 0.001) and concomitant cardiac procedures. Early mortality (TVR, 9% vs TVr, 3%; P = 0.004), renal failure (TVR, 10% vs TVr, 5%; P = 0.014) and hospital stay (TVR, 15 ± 15 days vs TVr, 12 ± 11 days; P < 0.001) were greater in TVR patients. The TVR cohort had worse survival [hazard ratio (HR) 1.57; 95% CI 1.23-1.99]. Multivariable analysis identified congestive heart failure (HR 1.37; 95% CI 1.10-1.72), renal failure (HR 1.79; 95% CI 1.14-2.82), previous MV surgery (HR 1.35; 95% CI 1.05-1.72) and TVR (HR 1.36; 95% CI 1.03-1.79) as independent risk factors for late mortality.
Tricuspid repair for fTR appears to have better early and late outcomes. Since previous MV surgery and TVR are identified as independent risk factors for late mortality, concomitant TVr at the time of index MV surgery may be considered. Early referral before the onset of advanced heart failure may improve outcomes.
功能性三尖瓣反流(fTR)可通过三尖瓣修复(TVr)治疗,需要行三尖瓣置换(TVR)的患者较少。我们旨在回顾我们治疗 fTR 的三尖瓣手术经验。
回顾性分析了 1993 年 1 月至 2018 年 6 月期间接受原发性 fTR 三尖瓣手术的成年患者(n=926;平均年龄 68.6±12.5 岁;67%为女性)。其中 767 例(83%)患者行 TVr(环成形术,67%;荷包成形术,33%),159 例(17%)行 TVR(生物瓣,87%;机械瓣,13%)。中位随访时间为 8.2 年[95%置信区间(CI)7.2-8.9 年]。
行 TVR 的患者中,更多的患者有严重右心室功能障碍(P<0.001)、严重三尖瓣反流(P<0.001)和充血性心力衰竭(P=0.001),而 TVr 组中则有更多的患者有严重二尖瓣反流(P<0.001)和伴发心脏手术。TVR 组的早期死亡率(TVR,9%比 TVr,3%;P=0.004)、肾衰竭(TVR,10%比 TVr,5%;P=0.014)和住院时间(TVR,15±15 天比 TVr,12±11 天;P<0.001)均较高。TVR 组的生存情况较差[风险比(HR)1.57;95%CI 1.23-1.99]。多变量分析确定充血性心力衰竭(HR 1.37;95%CI 1.10-1.72)、肾衰竭(HR 1.79;95%CI 1.14-2.82)、既往二尖瓣手术(HR 1.35;95%CI 1.05-1.72)和 TVR(HR 1.36;95%CI 1.03-1.79)是晚期死亡的独立危险因素。
针对 fTR 的三尖瓣修复似乎具有更好的早期和晚期结果。由于既往二尖瓣手术和 TVR 被确定为晚期死亡的独立危险因素,因此在指数二尖瓣手术时可同时进行 TVr。在出现晚期心力衰竭之前,早期转诊可能会改善预后。